Resumen de acción GNS
Genus plc opera como empresa de genética animal en Norteamérica, Latinoamérica, Reino Unido, resto de Europa, Oriente Medio, Rusia, África y Asia.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 2/6 |
Dividends | 3/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en GNS a partir de nuestros controles de riesgos.
Competidores de Genus plc
Historial de precios y rendimiento
Historical stock prices | |
---|---|
Current Share Price | UK£17.56 |
52 Week High | UK£27.98 |
52 Week Low | UK£14.78 |
Beta | 0.31 |
1 Month Change | 2.39% |
3 Month Change | -21.18% |
1 Year Change | -36.38% |
3 Year Change | -66.58% |
5 Year Change | -23.52% |
Change since IPO | 1,200.74% |
Noticias y actualizaciones recientes
Is Genus (LON:GNS) Using Too Much Debt?
Mar 25With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For
Mar 05Genus (LON:GNS) Has Affirmed Its Dividend Of £0.103
Feb 25Recent updates
Is Genus (LON:GNS) Using Too Much Debt?
Mar 25With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For
Mar 05Genus (LON:GNS) Has Affirmed Its Dividend Of £0.103
Feb 25Getting In Cheap On Genus plc (LON:GNS) Might Be Difficult
Jan 17Does This Valuation Of Genus plc (LON:GNS) Imply Investors Are Overpaying?
Dec 10We Think Genus (LON:GNS) Is Taking Some Risk With Its Debt
Nov 03Calculating The Intrinsic Value Of Genus plc (LON:GNS)
Sep 09Is Genus (LON:GNS) A Risky Investment?
Mar 29Is Genus (LON:GNS) Using Too Much Debt?
Dec 21It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year
Nov 17Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217
Oct 25Genus (LON:GNS) Is Paying Out A Dividend Of £0.217
Oct 11Genus' (LON:GNS) Dividend Will Be £0.217
Sep 11A Look At The Fair Value Of Genus plc (LON:GNS)
Sep 09A Look At The Intrinsic Value Of Genus plc (LON:GNS)
May 31Is Genus (LON:GNS) A Risky Investment?
Mar 29Genus (LON:GNS) Has Re-Affirmed Its Dividend Of UK£0.10
Feb 27Is Genus plc (LON:GNS) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 22With EPS Growth And More, Genus (LON:GNS) Is Interesting
Oct 29Here's Why Genus (LON:GNS) Can Manage Its Debt Responsibly
Oct 14Genus (LON:GNS) Could Easily Take On More Debt
Apr 05Is Genus' (LON:GNS) 235% Share Price Increase Well Justified?
Mar 18Trade Alert: The Independent Non-Executive Chairman Of Genus plc (LON:GNS), Iain G. Ferguson, Has Just Spent UK£73k Buying 150% More Shares
Feb 28I Ran A Stock Scan For Earnings Growth And Genus (LON:GNS) Passed With Ease
Feb 26How Much Of Genus plc (LON:GNS) Do Institutions Own?
Feb 01Genus plc (LON:GNS) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?
Dec 22Have Genus plc (LON:GNS) Insiders Been Selling Their Stock?
Dec 05Is Genus' (LON:GNS) Share Price Gain Of 195% Well Earned?
Nov 20Rentabilidad de los accionistas
GNS | GB Biotechs | Mercado GB | |
---|---|---|---|
7D | -2.0% | -2.4% | -1.4% |
1Y | -36.4% | -29.6% | -2.4% |
Rentabilidad vs. Industria: GNS obtuvo unos resultados inferiores a los del sector UK Biotechs , que el año pasado arrojó un rendimiento del -27%.
Rentabilidad vs. Mercado: GNS obtuvo unos resultados inferiores a los del mercado UK, que fue del -5.3% el año pasado.
Volatilidad de los precios
GNS volatility | |
---|---|
GNS Average Weekly Movement | 6.8% |
Biotechs Industry Average Movement | 7.5% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 11.5% |
10% least volatile stocks in GB Market | 2.7% |
Precio estable de las acciones: GNSha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de GNS (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
1994 | 3,500 | JK Kokke | www.genusplc.com |
Genus plc opera como empresa de genética animal en Norteamérica, Latinoamérica, Reino Unido, resto de Europa, Oriente Medio, Rusia, África y Asia. La empresa opera a través de tres segmentos: Genus PIC, Genus ABS y Genus Investigación y Desarrollo. Vende cerdos reproductores y semen para criar cerdos con diversas características para la producción porcina bajo la marca PIC.
Resumen de fundamentos de Genus plc
Estadísticas fundamentales de GNS | |
---|---|
Capitalización bursátil | UK£1.15b |
Beneficios(TTM) | UK£33.40m |
Ingresos (TTM) | UK£673.10m |
34.5x
Ratio precio-beneficio (PE)1.7x
Ratio precio-ventas (PS)¿Está GNS sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de GNS | |
---|---|
Ingresos | UK£673.10m |
Coste de los ingresos | UK£429.10m |
Beneficio bruto | UK£244.00m |
Otros gastos | UK£210.60m |
Beneficios | UK£33.40m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
Sep 05, 2024
Beneficios por acción (BPA) | 0.51 |
Margen bruto | 36.25% |
Margen de beneficio neto | 4.96% |
Ratio deuda/patrimonio | 40.7% |
¿Cómo se ha desempeñado GNS a largo plazo?
Ver rendimiento histórico y comparativa